協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/09/28 | 2,931 | 2,954 | 2,903 | 2,953 | +52 | +1.8% | 665,100 |
2020/09/25 | 2,900 | 2,918 | 2,883 | 2,901 | +13 | +0.5% | 625,200 |
2020/09/24 | 2,853 | 2,895 | 2,844 | 2,888 | +13 | +0.5% | 534,500 |
2020/09/23 | 2,895 | 2,898 | 2,862 | 2,875 | -27 | -0.9% | 580,200 |
2020/09/18 | 2,900 | 2,920 | 2,886 | 2,902 | +10 | +0.3% | 783,800 |
2020/09/17 | 2,870 | 2,903 | 2,858 | 2,892 | +17 | +0.6% | 403,700 |
2020/09/16 | 2,823 | 2,915 | 2,823 | 2,875 | +27 | +0.9% | 520,200 |
2020/09/15 | 2,841 | 2,848 | 2,813 | 2,848 | +10 | +0.4% | 505,300 |
2020/09/14 | 2,873 | 2,881 | 2,837 | 2,838 | -16 | -0.6% | 603,200 |
2020/09/11 | 2,879 | 2,879 | 2,786 | 2,854 | +15 | +0.5% | 993,900 |
2020/09/10 | 2,814 | 2,846 | 2,805 | 2,839 | +49 | +1.8% | 523,400 |
2020/09/09 | 2,822 | 2,822 | 2,775 | 2,790 | -63 | -2.2% | 698,600 |
2020/09/08 | 2,822 | 2,858 | 2,795 | 2,853 | +44 | +1.6% | 600,000 |
2020/09/07 | 2,842 | 2,850 | 2,798 | 2,809 | -36 | -1.3% | 469,400 |
2020/09/04 | 2,834 | 2,866 | 2,802 | 2,845 | -33 | -1.1% | 666,000 |
2020/09/03 | 2,870 | 2,878 | 2,839 | 2,878 | +100 | +3.6% | 1,075,900 |
2020/09/02 | 2,740 | 2,778 | 2,734 | 2,778 | +34 | +1.2% | 536,500 |
2020/09/01 | 2,742 | 2,768 | 2,727 | 2,744 | +2 | +0.1% | 556,600 |
2020/08/31 | 2,687 | 2,744 | 2,664 | 2,742 | +91 | +3.4% | 888,700 |
2020/08/28 | 2,731 | 2,731 | 2,597 | 2,651 | -73 | -2.7% | 1,009,000 |
2020/08/27 | 2,714 | 2,731 | 2,706 | 2,724 | +17 | +0.6% | 589,200 |
2020/08/26 | 2,742 | 2,749 | 2,685 | 2,707 | -42 | -1.5% | 693,500 |
2020/08/25 | 2,775 | 2,785 | 2,741 | 2,749 | -23 | -0.8% | 584,900 |
2020/08/24 | 2,775 | 2,784 | 2,760 | 2,772 | +15 | +0.5% | 294,200 |
2020/08/21 | 2,786 | 2,803 | 2,756 | 2,757 | -14 | -0.5% | 525,900 |
2020/08/20 | 2,733 | 2,773 | 2,730 | 2,771 | +20 | +0.7% | 451,800 |
2020/08/19 | 2,744 | 2,759 | 2,725 | 2,751 | +38 | +1.4% | 532,100 |
2020/08/18 | 2,727 | 2,727 | 2,694 | 2,713 | -5 | -0.2% | 423,200 |
2020/08/17 | 2,730 | 2,758 | 2,717 | 2,718 | -3 | -0.1% | 419,800 |
2020/08/14 | 2,710 | 2,735 | 2,690 | 2,721 | +7 | +0.3% | 1,260,500 |
2020/08/13 | 2,721 | 2,722 | 2,690 | 2,714 | +30 | +1.1% | 973,600 |
2020/08/12 | 2,691 | 2,691 | 2,635 | 2,684 | -7 | -0.3% | 849,600 |
2020/08/11 | 2,720 | 2,727 | 2,679 | 2,691 | -10 | -0.4% | 946,100 |
2020/08/07 | 2,724 | 2,734 | 2,660 | 2,701 | +16 | +0.6% | 687,000 |
2020/08/06 | 2,662 | 2,707 | 2,653 | 2,685 | +11 | +0.4% | 585,000 |
2020/08/05 | 2,706 | 2,717 | 2,669 | 2,674 | -23 | -0.9% | 739,700 |
2020/08/04 | 2,628 | 2,720 | 2,609 | 2,697 | +79 | +3% | 1,123,200 |
2020/08/03 | 2,614 | 2,624 | 2,564 | 2,618 | +18 | +0.7% | 1,328,900 |
2020/07/31 | 2,650 | 2,653 | 2,565 | 2,600 | -131 | -4.8% | 2,059,700 |
2020/07/30 | 2,701 | 2,736 | 2,681 | 2,731 | +31 | +1.1% | 1,011,600 |
2020/07/29 | 2,706 | 2,730 | 2,689 | 2,700 | -2 | -0.1% | 989,500 |
2020/07/28 | 2,697 | 2,719 | 2,679 | 2,702 | +16 | +0.6% | 856,900 |
2020/07/27 | 2,657 | 2,693 | 2,638 | 2,686 | -1 | ±0% | 984,700 |
2020/07/22 | 2,689 | 2,691 | 2,654 | 2,687 | -26 | -1% | 668,000 |
2020/07/21 | 2,710 | 2,718 | 2,682 | 2,713 | +37 | +1.4% | 1,287,400 |
2020/07/20 | 2,684 | 2,697 | 2,670 | 2,676 | +6 | +0.2% | 515,900 |
2020/07/17 | 2,667 | 2,678 | 2,650 | 2,670 | +2 | +0.1% | 489,100 |
2020/07/16 | 2,671 | 2,689 | 2,642 | 2,668 | -30 | -1.1% | 1,216,700 |
2020/07/15 | 2,723 | 2,723 | 2,671 | 2,698 | -36 | -1.3% | 1,028,200 |
2020/07/14 | 2,742 | 2,771 | 2,726 | 2,734 | -10 | -0.4% | 472,000 |
1201~
1250
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 264,000円 | -3.5% | -11.3% | 2.27% | 24.25倍 | 1.65倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 169,000円 | +0.9% | +380.2% | 4.62% | 23.28倍 | 2.00倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 260,500円 | +20.9% | +10.6% | 2.53% | 12.31倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 468,400円 | +0.1% | -3.4% | 3.42% | 31.84倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 165,600円 | +0.6% | +43.3% | 4.83% | 11.62倍 | 0.99倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム